Alterity Therapeutics Ltd ADR (ATHE) is looking forward to a strong quarter

With 1.0 million shares changed hands, the volume of the stock remained heavier than its average volume of 43670.0 shares. The 52-week range on ATHE shows that it touched its highest point at $5.87 and its lowest point at $1.00 during that stretch. It currently has a 1-year price target of $11.78. Beta for the stock currently stands at 0.72.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ATHE was up-trending over the past week, with a rise of 25.00%, but this was up by 48.32% over a month. Three-month performance dropped to -4.81% while six-month performance rose 271.16%. The stock gained 104.23% in the past year, while it has gained 31.42% so far this year. A look at the trailing 12-month EPS for ATHE yields -1.58 with Next year EPS estimates of -0.90. For the next quarter, that number is -0.43. This implies an EPS growth rate of 62.06% for this year and -33.90% for next year. EPS is expected to grow by 21.94% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 24.86%.

Float and Shares Shorts:

At present, 15.21 million ATHE shares are outstanding with a float of 14.50 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ATHE since 0 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.65612 being high and -$1.65612 being low. For ATHE, this leads to a yearly average estimate of -$1.65612. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.